Jiangsu GDK Biotechnology Co Ltd (688670) — Capital Reinvestment Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Capital Reinvestment Ratio of 0.67x as of December 2023, meaning it reinvests 1% of its operating cash flow (CN¥80.90 Million) in capital expenditures (CN¥54.00 Million). See net asset quality index of Jiangsu GDK Biotechnology Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu GDK Biotechnology Co Ltd Capital Reinvestment Ratio (2020–2023)
This chart tracks Jiangsu GDK Biotechnology Co Ltd's Capital Reinvestment Ratio across 4 annual periods. Check Jiangsu GDK Biotechnology Co Ltd (688670) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu GDK Biotechnology Co Ltd (2020–2023)
Year-by-year Capital Reinvestment Ratio for Jiangsu GDK Biotechnology Co Ltd from 2020 to 2023. For live market cap and broader valuation context, see market value of Jiangsu GDK Biotechnology Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | CN¥80.90 Million | CN¥54.00 Million | ▼ -84.7% |
| 2022 | 4.36x | CN¥38.60 Million | CN¥168.18 Million | ▲ +17.2% |
| 2021 | 3.72x | CN¥103.93 Million | CN¥386.39 Million | ▲ +897.2% |
| 2020 | 0.37x | CN¥109.46 Million | CN¥40.81 Million | — |